Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients

American Journal of Kidney Diseases

Volumn 41, Issue 3, 2003, Pages 616-623

  Yildiz, Alaattin ^a   Oflaz, Huseyin ^b   Pusuroglu, Hamdi ^b   Mercanoglu, Fehmi ^b   Genchallac, Hakan ^b   Akkaya, Vakur ^b   Ikizler, T Alp ^b   Sever, Mehmet S ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Anemia; Endothelial dysfunction (ED); Flow mediated dilatation; Hemodialysis (HD); Left ventricular hypertrophy (LVH)

Indexed keywords

ADULT; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELASTICITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 0037374195     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50123     Document Type: Article

References (33)

1. US Renal Data System: 1998 Annual Report. Am J Kidney Dis 32:S81-S88, 1998 (suppl 1)
2. London GM, Pannier B, Guerin AP, et al: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767, 2001
3. London GM, Parfrey PS: Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 4:194-211, 1997
4. van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD: Endothelium-dependent vasodilatation and distensibility of large arteries in chronic hemodialysis patients. Nephrol Dial Transplant 12:S14-S18, 1997 (suppl 2)
5. Perticone F, Mairo R, Ceravolo R, Cosco C, Cloro C, Mattioli PL: Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation 99:1991-1996, 1999
6. Millgard J, Hagg A, Kahan T, et al: Left ventricular hypertrophy is associated with an attenuated endothelium-dependent vasodilation in hypertensive men. Blood Press 9:309-314, 2000
7. Motoyama T, Kawano H, Hirai N, et al: The relationship of left ventricular mass to endothelium-dependent vasodilation of the brachial artery in patients with hypertension. Cardiology 96:7-15, 2001
8. Declaration of Helsinki. Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects, 41st World Medical Assembly, Hong Kong, September, 1989
9. Friedewald WT, Levy RI, Fredrickson DS: Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
10. Henry WL, DeMaria A, Gramiak R, et al: Report of the American Society of Echocardiography Committee on nomenclature and standards in two dimensional echocardiography. Circulation 62:212-217, 1980
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083, 1978
12. Devereux RB, Koren MJ, de Simone G, Okin PM, Kligfield P: Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur Heart J 14:S8-S15, 1993 (suppl D)
13. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618, 1977
14. Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
15. Middleton RJ, Parfrey PS, Foley RN: Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079-1084, 2001
16. Verma S, Anderson TJ: Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:546-549, 2002
17. Corretti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265, 2002
18. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205-209, 2000
19. van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Stehouwer CD: Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13:1782-1786, 1998
20. Morris ST, McMurray JJ, Spiers A, Jardine AG: Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60:1077-1082, 2001
21. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M: Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 55:1104-1110, 1999
22. Ovuworie CA, Fox ER, Chow CM, et al: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients., Transplantation 72:1385-1388, 2001
23. Muiesan ML, Salvetti M, Monteduro C, et al: Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens 19:641-647, 2001
24. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London GM: Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57:1091-1099, 2000
25. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575, 1992
26. Bolton CH, Downs LG, Victory JG, et al: Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16:1189-1197, 2001
27. Zoccali C, Mallamaci F, Maas R, et al: Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62: 339-345, 2002
28. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10:610-619, 1999
29. Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of the knowledge. Kidney Int Suppl 80:S35-S38, 2002
30. London GM, Guerin AP, Marchais SJ, et al: Cardiac and arterial interactions in end stage renal disease. Kidney Int 50:600-608, 1996
31. Passauer J, Bussemaker E, Range U, Plug M, Gross P: Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis. J Am Soc Nephrol 11:1726-1734, 2000
32. Lopez-Jaramillo P, Casas JP: Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists. J Hum Hypertens 16:S34-S37, 2002 (suppl 1)
33. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G: Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 40:728-736, 2002